Market Research Reports

Equine Healthcare Market (Diagnostic Products, Therapeutic Products and Supplement Products) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

120pages
Published Date: 2013-12-13
 

Description


The global equestrian market is a multi-billion dollar industry that comprises horse racing and betting, leisure and competitive riding and has spawned and supports multifarious secondary markets; the equine healthcare market ranks as the one of the key secondary markets. This report exclusively studies the market for equine healthcare from varied aspects such as, in terms of equine diagnostic products, equine therapeutic products and equine supplement products; and is thus classified into three prime segments namelyequine diagnostic products market, equine therapeutic products market and equine supplement products market. The market size and forecast for the period 2013–2019, in terms of USD million, considering 2012 as the base year has been provided for each segment and sub-segments in the report. The compound annual growth rate (CAGR) for each segment and sub-segments has been provided for the forecast period from 2013–2019.

Geographically, the equine healthcare market has been classified into four regions -North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region along with their market growth rate has been highlighted. The market overview section of the report comprises of a qualitative analysis of the market in terms of drivers, restraintsand opportunities, along with market attractiveness analysis.

The report concludes with the competitive landscape and company profiles of few market players in this industry, as of 2012. The market players profiled in this report include Elanco Animal Health, Merck Animal Health, Zoetis (Pfizer Animal Health), Boehringer Ingelheim Vetmedica, Bayer Animal Health, Equine Health U.K., Equine Orthotics and Prosthetics, Affymetrix, Equine Diagnostics, Signostics and Purina.

The global equine healthcaremarket is segmented as follows:

Equine Diagnostic Products Market, by Type
  • Equine Pregnancy and Gestation Diagnostic Products Market
    • Equine UltraSound Devices Market
    • Equine Urine Test Kits Market
  • Equine Genotyping Analysis Products Market
    • Breed Quality Analyzers/Genotype Analyzers Kits Market
    • Genetic Disease Identification Products/Semen Quality Analyzers Market
Equine Therapeutic Products Market, by Type
  • Equine Vaccines Market
  • Equine Antibacterials Market
  • Equine Antivirals Market
  • Equine Antiprotozoals Market
  • Equine Dopamine Agonists Market
  • Equine Anti-inflammatory Drugs Market
  • Equine Laxatives Market
Equine Supplement Products Market, by Type
  • Equine Performance Supplements Market
    • Equine Proteins and Amino Acids Supplements Market
    • Equine Vitamin Supplements Market
    • Equine Electrolyte Supplements Market
    • Other Equine Performance Supplements Market
  • Equine Protection Products Market
    • Equine Protection Products Market
    • Equine Prosthetics Market
Equine Healthcare Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents


Table of Contents

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions

Chapter 2 Executive Summary

Chapter 3 Global Equine Healthcare Market Overview
3.1 Definition - Equine Healthcare
3.2 Significance of Equestrian Industry and Equine Healthcare
3.3 Drivers
      3.3.1 High ROI Attracts Market Participants and Expands the Market
      3.3.2 Multiple Support or Secondary Markets Drive Growth
      3.3.3 Newer Geographical Regions Investing in Horse Racing and Betting
      3.3.4 Initiatives by Equine Healthcare Organizations and Market Participants
3.4 Restraints
      3.4.1 Declining global equine population
      3.4.2 Alternative Forms of Gambling such as ‘Online Betting/Gaming’ on the fore of ‘Legal’ Status
3.5 Opportunities
      3.5.1 Equine Healthcare Sub-Segment Markets - Opportunity Matrix
      3.5.2 Asia-Pacific Market - Niche Opportunity
3.6 Porter’s Five Forces Analysis
      3.6.1 Bargaining Power of Suppliers
      3.6.2 Bargaining Power of Buyers
      3.6.3 Threat of New Entrants
      3.6.4 Threat of Substitutes
      3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis: Global Equine Healthcare Market, by Geography

Chapter 4 Global Equine Diagnostic Products Market, by Type, 2011 - 2019 (USD Million)
4.1 Equine Pregnancy and Gestation Diagnostic Products Market
      4.1.1 Equine UltraSound Devices Market
              4.1.1.1 Global Equine UltraSound Devices Market, Value, 2011 - 2019 (USD Million)
      4.1.2 Equine Urine Test Kits Market
              4.1.2.1 Global Equine Urine Test Kits Market, Value, 2011 - 2019 (USD Million)
4.2 Equine Genotyping Analysis Products Market
      4.2.1 Global Equine Genotyping Analysis Products Market, Value, 2011 - 2019 (USD Million)
      4.2.2 Breed Quality Analyzers/Genotype Analyzers Kits Market
      4.2.3 Genetic Disease Identification Products/Semen Quality Analyzers Market

Chapter 5 Global Equine Therapeutic Products Market, by Type, 2011 - 2019 (USD Million)
5.1 Equine Vaccines Market
      5.1.1 Global Equine Vaccines Market, Value, 2011 - 2019 (USD Million)
5.2 Equine Therapeutic Products Market
      5.2.1 Equine Antibacterials Market
              5.2.1.1 Global Equine Antibacterials Market, Value, 2011 - 2019 (USD Million)
      5.2.2 Equine Antivirals Market
              5.2.2.1 Global Equine Antivirals Market, Value, 2011 - 2019 (USD Million)
      5.2.3 Equine Antiprotozoals / Dewormers Market
              5.2.3.1 Global Equine Antiprotozoals/Dewormers Market, Value, 2011 - 2019 (USD Million)
      5.2.4 Equine Dopamine Agonists Market
              5.2.4.1 Global Equine Dopamine Agonists Market, Value, 2011 - 2019 (USD Million)
      5.2.5 Equine Anti-inflammatory Drugs Market
              5.2.5.1 Global Equine Anti-inflammatory Drugs Market, Value, 2011 - 2019 (USD Million)
      5.2.6 Equine Laxatives Market
              5.2.6.1 Global Equine Laxatives Market, Value, 2011 - 2019 (USD Million)

Chapter 6 Global Equine Supplement Products Market, by Type, 2011 - 2019 (USD Million)
6.1 Equine Performance Supplements Market
      6.1.1 Global Equine Performance Supplements Market, Value, 2011 - 2019 (USD Million)
      6.1.2 Equine Proteins and Amino Acids Supplements Market
      6.1.3 Equine Vitamin Supplements Market
      6.1.4 Equine Electrolyte Supplements Market
      6.1.5 Other Equine Performance Supplements Market
6.2 Equine Protection Products Market
      6.2.1 Equine Protection Products Market
              6.2.1.1 Global Equine Protection Products Market, Value, 2011 - 2019 (USD Million)
      6.2.2 Equine Prosthetics Market
              6.2.2.1 Global Equine Prosthetics Market, Value (in USD Million)

Chapter 7 Global Equine Healthcare Market, by Geography, 2011 - 2019 (USD Million)
7.1 Introduction
      7.1.1 Global Equine Healthcare Market, by Geography, 2011 - 2019 (USD Million)
7.2 North America Equine Healthcare Market: Market Size, 2013 and 2019 (USD Million)
7.3 Europe Equine Healthcare Market: Market Size, 2013 and 2019 (USD Million)
7.4 Asia-Pacific Equine Healthcare Market: Market Size, 2013 and 2019 (USD Million)
7.5 Rest of the World (RoW) Equine Healthcare Market: Market Size, 2013 and 2019 (USD Million)

Chapter 8 Company Profiles
8.1 Affymetrix, Inc.
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Bayer
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Strategic Overview
8.3 Boerhringer Ingelheim Vetmedica, Inc. (BIVI)
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Strategic Overview
8.4 Elanco Animal Health
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Strategic Overview
8.5 Equine Diagnostics
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product/Services Portfolio
      8.5.4 Strategic Overview
8.6 Equine Orthotics and Prosthetics
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Strategic Overview
8.7 Equine Products (UK) Ltd.
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Strategic Overview
8.8 Merck Animal Health
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Strategic Overview
8.9 Purina Mills, LLC
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Strategic Overview
8.10 Signostics Limited
      8.10.1 Company Overview
      8.10.2 Financial Overview
      8.10.3 Product Portfolio
      8.10.4 Strategic Overview
      8.10.5 Recent Developments
8.11 Zoetis, Inc.
      8.11.1 Company Overview
      8.11.2 Financial Overview
      8.11.3 Products/Services Portfolio
      8.11.4 Strategic Overview

List of Figures

Fig. 1 Equine Healthcare Market: Market Segmentation
Fig. 2 Global Equine Healthcare Market, By Segments, 2012, Value (USD Million)
Fig. 3 Equine Healthcare: Economic Impact
Fig. 4 Equine Healthcare: Supports Multiple Secondary Markets
Fig. 5 Porter’s Five Forces Analysis for Equine Therapeutic Market
Fig. 6 Market Attractiveness Analysis: Global Equine Healthcare Market, By Geography
Fig. 7 Global Equine Ultrasound Devices Market, Value, 2011 - 2019 (USD Million)
Fig. 8 Global Equine Urine Test Kits Market, Value, 2011 - 2019 (USD Million)
Fig. 9 Global Equine Genotyping Analysis Products Market, Value, 2011 - 2019 (USD Million)
Fig. 10 Global Equine Vaccines Market, Value, 2011 - 2019 (USD Million)
Fig. 11 Global Equine Antibacterials Market, Value, 2011 - 2019 (USD Million)
Fig. 12 Global Equine Antivirals Market, Value, 2011 - 2019 (USD Million)
Fig. 13 Effect of Dewormers Dosage Optimization
Fig. 14 Global Equine Antiprotozoals/Dewormers Market, Value, 2011 - 2019 (USD Million)
Fig. 15 Effect of Cushing’s Disease : Healthy Horse and Horse Suffering From Cushing’s Disease
Fig. 16 Global Equine Dopamine Agonists Market, Value, 2011 - 2019 (USD Million)
Fig. 17 Global Equine Anti-Inflammatory Drugs Market, Value, 2011 - 2019 (USD Million)
Fig. 18 Global Equine Laxatives Market, Value, 2011 - 2019 (USD Million)
Fig. 19 Global Equine Performance Supplements Market, Value, 2011 - 2019 (USD Million)
Fig. 20 Global Equine Protection Products Market, Value, 2011 - 2019 (USD Million)
Fig. 21 Global Equine Prosthetics Market, Value, 2011 - 2019 (USD Million)
Fig. 22 Global Equine Healthcare Market, By Geography, 2011 - 2019 (usd Million)
Fig. 23 Comparative Analysis: Equine Healthcare Market, North America, 2013 and 2019 (Usd Million)
Fig. 24 Comparative Analysis: Equine Healthcare Market, Europe, 2013 and 2019 (Usd Million)
Fig. 25 Comparative Analysis: Equine Healthcare Market, Asia-Pacific, 2013 and 2019 (USD Million)
Fig. 26 Comparative Analysis: Equine Healthcare Market, Row, 2013 and 2019 (USD Million)
Fig. 27 Affymetrix: Annual Sales Revenue, 2010 – 2012 (USD Million)
Fig. 28 Bayer Ag: Annual Sales Revenue, 2011 – 2013 (USD Million)
Fig. 29 Boehringer Ingelheim Vetmedica: Annual Sales Revenue, 2011 – 2013 (USD Million)
Fig. 30 Elanco Animal Health: Annual Sales Revenue, 2011 – 2013 (USD Million)
Fig. 31 Merck Animal Health: Annual Sales Revenue, 2011 – 2013 (USD Million)
Fig. 32 Zoetis, Inc.: Annual Sales Revenue, 2011 – 2013 (USD Million)

List of Tables

Table 1 Market Snapshot: Global Equine Healthcare Market
Table 2 Global Equine Diagnostic Products Market, Value, 2011 - 2019 (USD Million)
Table 3 Global Equine Therapeutic Products Market, Value, 2011 - 2019 (USD Million)
Table 4 Global Equine Supplement Products Market, Value, 2011 - 2019 (USD Million)

Enquiry Before Buying


Free Market Analysis


The global equestrian market is a multi-billion dollar industry that comprises horse racing, leisure and competitive riding has spawned and supports multifarious supplementary or secondary markets; the equine healthcare market ranks as the prime support or secondary market. The study of the equine healthcare market is thus beneficial to understand multitude of opportunities and niche markets that can be leveraged and catered to by the market participants.

The equine healthcare market is segmented into equine diagnostic products, equine therapeutic products and equine supplement products. These three segments comprise of sub-segment markets in context of various products used for diagnosis of equine-specific healthcare conditions, treatment of equine-specific healthcare conditions and supplements and protection products used for upkeep and maintenance of a horse, respectively.

The base of sustainability and profitability of the equestrian industry is the population/number of horses worldwide, any change in the equine population impacts the equestrian industry and the support or secondary markets such as the equine healthcare market.

A trend analysis in congruence with expert opinion analysis indicates that to maximize ROI of equestrian business operations, horse-owners are likely to curtail equestrian operations only till ‘breeding’ sub-set of the value-chain that yields high ROI. Horse ‘breeding’ is thus expected to be a core equestrian industry/market in some geographical regions. Choice of breeding stock and management of breeds are crucial to maintain and improve profitability margins of breeding operations.Additionally, it is expected that going forward, regulatory compliance norms mandate ‘genotype tagging/labeling’ of the meat source i.e. slaughtered animal/horse, to thwart the spread of infections from horses to humans. Choice of breeding stock and genotype tagging/labeling’ are done with the help of ‘breed quality analyzers/genotype analyzers kits’ that constitute the equine genotyping analysis products market. Hence, we estimate the global equine genotyping analysis products market (a sub-segment of the equine diagnostic productsmarket) to grow at a substantially high (as compared to other market segments) CAGR of over 15% during years 2013 to 2019.

Going forward till 2019, ~50% of the horse-owners in the North American region indicated declining interests in participating in equine shows, events and also racing. The horse-owners also opined that they are likely to curtail equestrian operations only till ‘breeding’ sub-set of the value-chain in order to maximize the ROI and export quality breed horses to destinations such as China. Hence, the North American equine healthcare market is expected to decline by ~1.0% over the six years from 2013 to 2019.

global-equine-healthcare-market-by-segments-2012-value
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research